Clinical trial
Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin…
NCT00025753 · National Center for Research Resources (NCRR), NIH · Completed
Key facts
| NCT number | NCT00025753 |
|---|---|
| Title | Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue Maldistribution |
| Official title | Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue Maldistribution |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | The Campbell Foundation |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections, Insulin Resistance |
| Intervention type | Behavioral, Drug |
| Interventions | rosiglitazone (Avandia), Aerobic and weight lifting exercise training |
| First posted | Oct 22, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: